Tag: pharmacokinetics (PK)
Clinical Data Supporting neffy® Epinephrine Nasal Spray Presented at Scientific Meeting
Data builds the case for prompt FDA approval.
Needle-Free Powder Epinephrine Nasal Spray Shows Positive Results in Clinical Study
"Powder-based products are also known to have better stability, as compared to the solution-based products."
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data For Anaphylm™ (Epinephrine) Sublingual...
"Anaphylm allows patients to have medication with them where they need it, when they need it and is convenient enough to carry in their wallets or pockets.”
Viatris, Seller of EpiPen®, Petitions FDA to Delay Approval of neffy™...
A ploy to delay introduction of neffy.
Sublingual Epinephrine Faster to Maximum Concentration than Auto-Injector, Syringe
Researchers observed early and robust increases in systolic and diastolic blood pressure and pulse with AQST-109.
Needle-Free, Sublingual Epinephrine Film Works Faster Than Auto-Injectors According to Study
Results from a 12mg formulation were comparable to intramuscular administration.
FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...
If approved, acceptance targeted for mid-2023.
Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...
The company announced topline results from their EPIPHAST II study.
Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis
Nasal administration of epinephrine takes another step forward.
Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration
Company presented top level Phase 1 results at #AAAAI2022 meeting.
